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+18 and 177+57 msecaftermitralvalveopening.
Results:Mitralscorewee7 + 2 withmeangradientof 6.0 + 2.7 mmHg.
Thevalvearaasby ColorM-mode(1.47* 0.38cm?)wasnot significantly
differentfrom2D, PHTand PISAmethods(1.49+ 0.42, 1.47l 0.30and
1.37+ 0.36cn# respectively).MVAesdeterminedbyColorM-modedidnot
differfromeither2D(p= 0.57),PHT(p=0.S8)or PISA(p= 0.14).Thetimed
calculationsehowedmarkedchangesin flowwithoutchangesinvalvearea
asnotadbelow.
Eady Diastole Mid Dlsatole p value
Flow (mlkao) 247*62 189*.53 <0001
VelcoWa (crrdaac) 173 *39 129 +30 <0.301
MVA (cmz) 1,47+ 0.36 1.51 * 0.40 0.27
ColorM-modeMVAcorrelatedwellwiththe3 referencemethodsin early
and middiaatole.2D (r= O.&lp <0.01 vs. r = 0.69p <0.01 respectively),
PHT(r= 0.85p< 0.01vs.r= 0.48p <0.05 reepactively)andPISA(r= 0.69
p <0.01 ve.r = 0.53p <0.05 respectively).
Cone/ushrrs:In patient6with mitralstenoaiacolorM-modeanalysieof











accurateasseaamentof LVeystolicfunctionia necesaaryfor optimaltiming







by 2-D Echocardiographyusingthe modifiedSimpaon’erule.A aignificent
numberof patientswho did not fulfill the crfteriafor surgicaldecisionby
M-modedimensionsand FS hadvolumesexceedingacceptedcriteriaand
reducwlEF.Ofthe54patientswithmitralregurgitation,30patientshadEF<
55%end18onlyhadFS< 31%.Of the57 patientswithaorticregurgitation
35 hadEF < W% whileFSwas-=29%in only15patients.Thuein 22%of
the patientswith mitralregurgitationand in 35%of the patientswithaortic
regurgitationthe LVimpairmentindicatedbyvolumedatawouldhavebeen
missedif relyingonthe reportadM-modedata.
Conclusion:Due to changesin shapeand in longitudinalshortening,
quantitative2-D echocardiographiodaeseaementof LV volumesand EF
mayprovidea betterassessmentfor timingof aurgeryin”aorticand mitral
regurgitation.
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L.Crouee,C. Pollickfor the FS089Multi-CenterStudyGroup.Mo/ecu/ar
Biosyateme,lm., SanDiego,CA,USA
FS069is a newultrasoundcontrastagentcomprisedof perfluoropanefilled
albumin-shellmicrosphere.Itaaafetyandefficacyfor improvingtheasaasa-
mentofleftventncular(LV)functionweremmparadwiththoaeofALBUNEX@
(ALB)in 203 patienta(180 males-79%:43 females-21%).74 of thesepa-
tientsformedaaubgroupwithimpairedLVancUorpulmonavfunction,factors
knownto limitALBefficacy.0.0Sand0.22mUkgALBand0.2,0.5, 3.0and
5.0 mL of FS089weregivenIV.LVendocardialborderdelineation(EBD)
andLVchamberopacifioation(LVO)wereaaaeasedbyblindedreviewwith
resultsof0.22mL/kgALBand3.0mLFS069reported.Adverseeventawere
noted in 8.9%of patientsfollowingALB and 6.6% followingFS089.End
diastolicendocardiumincreasedin lengthby3.45cmwithALBVS. 7.44cm
withFS069,p <0.0001 whilesystolicendocardialengthincreasedby 1.56
cmwithALBve4.81cmwithFS089,p <0.0001. EBDimprovedbyoneor
moresegments(of6 totalfromapical4 chamberview)in 75%of ail patients
withALBve.93%withFS088,p <0.0001. LVOof 2 2+ (ona scaleof Oto
3+)occurredinE6%ofallpatiantawithALBve.93%withFS069,p -z0.0001.
In the impaired function subgroup, LVOof > 2+ was38%withALBvs 91%
withFS049,p <0.0001.Theserasultsdemorretretethesafetyof FS069with
euperiorefficacyto ALBforall patienteregardlessof the prasenceof factors
whichinhibitcontrastefficacy.





Pwpose:Bedaideevaluationof the repeatabilityof LV chambersize and
functionestimatesfrom an ABD algorithmfor epicardialand endocardial
borderdetection.





in time.Fiveindependentobservera,3 trainedand 2 in-training,tracedthe
epi-andendooardialbordersat EDandES.Chamberareasat EDand ES,
fractionalareachange(FAC),and musclearea(MA)werecalculated.Ob-
serverandABDstandarddeviation (SD)werecalculatedforthedifferences




Obaarver SD’a 1 2 3 4 5 ABD
EndoED (cm2) 2.s9 3.24 3.1s 2.34 4.78 2.72
EndoES (cm2) 1.80 2.66 1.50 1.86 2.00 2,15
MA (c#) 1.96 3.28 2.43 2.7S 0.43 2.27
FAC (%) 4.4 7.6 6.6 7.3 14.0 4.9










In order to evaluatethe enhancementof left ventricular(LV)endocardial
borderdelineationduringdobutamineatreaaachocardiogrephy(DSE),soni-
catedHumanAlbumin(Infoaon’”:NycomedimagingNorway)wasinfusedat




doseof dobufamineand Infoaon’”infusion’was36 + 6 @kg/mm and 10.5
+ 1 mlkg reepaotively.
Morethan60%of theinjection reaultedin intermediateor full LVopacifi-
cetion.Noeignificanteideeffectarelatedto Infosonwinfueionwereobserved.
Noaignifioantdifferencewaaobeewedwithregardto LVEFbeforeandafter
Infuson’”infueionat baaeiine(60& 11versus65 + 10%,respectively)and
peak(59+ 13versus61 + 10%).Viaualanalogaoaleascoresgradingthe
abilityto detectthe LVendocardialborderawere not significantlydifferent
beforeandafterlnfoaon”injection.knagequalitywaainchangedby lnfoeonN
injectionin the majorityof patienta.Finaily,the probabilityof concordance




venously,thisdid not improveLVendocardialborderdelineationnor did it
facilitatewallmotionanalysiain thisstudy,
